SCA
ELV icon

Snowden Capital Advisors’s Elevance Health ELV Stock Holding History

Snowden Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
3,042
+579
+24% +$215K 0.03% 515
2026
Q1 		$721K Buy
2,463
+72
+3% +$23.7K 0.02% 645
2025
Q4 		$838K Sell
2,391
-18
-0.7% -$6.08K 0.02% 600
2025
Q3 		$778K Sell
2,409
-447
-16% -$139K 0.02% 604
2025
Q2 		$1.11M Buy
2,856
+1
+0% +$402 0.03% 481
2025
Q1 		$1.24M Buy
2,855
+691
+32% +$277K 0.04% 432
2024
Q4 		$798K Sell
2,164
-533
-20% -$223K 0.02% 585
2024
Q3 		$1.4M Sell
2,697
-7
-0.3% -$3.74K 0.04% 426
2024
Q2 		$1.46M Sell
2,704
-92
-3% -$48.6K 0.04% 402
2024
Q1 		$1.45M Buy
2,796
+755
+37% +$375K 0.05% 407
2023
Q4 		$962K Sell
2,041
-242
-11% -$112K 0.04% 452
2023
Q3 		$994K Sell
2,283
-252
-10% -$114K 0.04% 421
2023
Q2 		$1.13M Buy
2,535
+129
+5% +$59.5K 0.04% 426
2023
Q1 		$1.11M Sell
2,406
-14,738
-86% -$7.01M 0.04% 434
2022
Q4 		$8.79M Sell
17,144
-688
-4% -$349K 0.37% 47
2022
Q3 		$8.1M Sell
17,832
-599
-3% -$287K 0.37% 46
2022
Q2 		$8.89M Sell
18,431
-471
-2% -$233K 0.4% 43
2022
Q1 		$9.29M Buy
18,902
+17,410
+1,167% +$7.96M 0.37% 53
2021
Q4 		$691K Sell
1,492
-1,723
-54% -$725K 0.04% 398
2021
Q3 		$1.2M Buy
3,215
+78
+2% +$29.6K 0.06% 335
2021
Q2 		$1.2M Sell
3,137
-668
-18% -$255K 0.06% 341
2021
Q1 		$1.37M Buy
3,805
+2,281
+150% +$734K 0.08% 292
2020
Q4 		$489K Sell
1,524
-153
-9% -$47K 0.03% 446
2020
Q3 		$450K Sell
1,677
-2
-0.1% -$538 0.04% 407
2020
Q2 		$442K Buy
+1,679
New +$448K 0.04% 401
2018
Q4 		– Sell
-756
Closed -$207K – 475
2018
Q3 		$207K Buy
+756
New +$196K 0.02% 469

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Snowden Capital Advisors's ELV Position: Q2 2026 in Review

Snowden Capital Advisors increased its Elevance Health (ELV) stake by 24% in Q2 2026, buying an estimated $215K and bringing the position to 3,042 shares worth $1.18M. The position accounts for 0.03% of the portfolio, ranked #515.

Snowden Capital Advisors first reported a position in ELV in Q3 2018 and has held it in 26 quarters since. The position peaked at $9.29M in Q1 2022. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Snowden Capital Advisors held 3,042 shares of Elevance Health worth $1.18M as of Q2 2026.
  • Snowden Capital Advisors bought 579 Elevance Health shares in Q2 2026, an estimated $215K.
  • Elevance Health made up 0.03% of Snowden Capital Advisors's portfolio in Q2 2026, its #515 holding.
  • Snowden Capital Advisors first reported a position in Elevance Health in Q3 2018 and has held it in 26 quarters since.
  • Snowden Capital Advisors's Elevance Health position peaked at $9.29M in Q1 2022.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.